We already knew this... but for those that don't..
Fact - PPL-1 is effective against cancer in the lowest dose.
Does PPL-1 work in cancer? Although it often takes many years for a new anticancer drug to reach the marketplace, we have evidence in our first trial (Phase I/II) and at the lowest dose that PPL-1 is acting and suppressing a key tumour marker. If all we showed was that PPL-1 was safe and without adverse events we would consider the trial a success, however, having evidence showing PPL-1 is active in patients that have failed all “standards of care” is a major bonus to our “first in man” evaluation.
Ann: Appendix 4C Quarterly Report & Company Update, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $89.08M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $170.5K | 749.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34313 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 24444 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 22.0¢ | 246904 | ||
| Last updated 15.57pm 14/06/2024 ? | |||||
| PAA (ASX) Chart |